Transcriptomic Analysis of Vulvovaginal Candidiasis Identifies a Role for the NLRP3 Inflammasome

mBio

Volumn 6, Issue 2, 2015, Pages 1-15

  Bruno, Vincent M ^a   Shetty, Amol C ^a   Yano, Junko ^b   Fidel, Paul L ^b,c   Noverr, Mairi C ^b,c   Peters, Brian M ^b  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^c LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALARMIN; ASPARTIC PROTEINASE; BIOLOGICAL FACTOR; CRYOPYRIN; GLIBENCLAMIDE; HYPHA ASSOCIATED SECRETED ASPARTYL PROTEINASE 4; HYPHA ASSOCIATED SECRETED ASPARTYL PROTEINASE 5; HYPHA ASSOCIATED SECRETED ASPARTYL PROTEINASE 6; INTERLEUKIN 1BETA; UNCLASSIFIED DRUG; CARRIER PROTEIN; CIAS1 PROTEIN, MOUSE; INFLAMMASOME; VIRULENCE FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANDIDA ALBICANS; CONTROLLED STUDY; FUNGAL COLONIZATION; FUNGAL GENE; FUNGAL VIRULENCE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENETIC ASSOCIATION; HOST PATHOGEN INTERACTION; IMMUNE RESPONSE; IMMUNOPATHOGENESIS; MOUSE; NEUTROPHIL COUNT; NONHUMAN; PRIORITY JOURNAL; RNA SEQUENCE; SAP4 GENE; SAP5 GENE; SAP6 GENE; SIGNAL TRANSDUCTION; TH17 CELL; TRANSCRIPTOMICS; VAGINA CANDIDIASIS; VAGINA DISCHARGE; VAGINA MUCOSA; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; DISEASE MODEL; DNA SEQUENCE; FEMALE; GENETICS; GROWTH, DEVELOPMENT AND AGING; IMMUNOLOGY; KNOCKOUT MOUSE; METABOLISM; MICROBIOLOGY; MOLECULAR GENETICS; NEUTROPHIL; PATHOLOGY; VAGINA;

CANDIDA ALBICANS; MURINAE; MUS;

ANIMALS; CANDIDA ALBICANS; CANDIDIASIS, VULVOVAGINAL; CARRIER PROTEINS; DISEASE MODELS, ANIMAL; FEMALE; GENE EXPRESSION PROFILING; INFLAMMASOMES; MICE, INBRED C57BL; MICE, KNOCKOUT; MOLECULAR SEQUENCE DATA; NEUTROPHILS; SEQUENCE ANALYSIS, DNA; VAGINA; VIRULENCE FACTORS;

EID: 84928809226     PISSN: 21612129     EISSN: 21507511     Source Type: Journal    
DOI: 10.1128/mBio.00182-15     Document Type: Article

References (104)

1. Redding SW, Zellars RC, Kirkpatrick WR, McAtee RK, Caceres MA, Fothergill AW, Lopez-Ribot JL, Bailey CW, Rinaldi MG, Patterson TF. 1999. Epidemiology of oropharyngeal Candida colonization and infection in patients receiving radiation for head and neck cancer. J Clin Microbiol 37:3896–3900.
2. Revankar SG, Dib OP, Kirkpatrick WR, McAtee RK, Fothergill AW, Rinaldi MG, Redding SW, Patterson TF. 1998. Clinical evaluation and microbiology of oropharyngeal infection due to fluconazole-resistant Candida in human immunodeficiency virus-infected patients. Clin Infect Dis 26:960–963. http://dx.doi.org/10.1086/513950.
3. Rhodus NL, Bloomquist C, Liljemark W, Bereuter J. 1997. Prevalence, density, and manifestations of oral Candida albicans in patients with Sjogren’s syndrome. J Otolaryngol 26:300–305.
4. Sangeorzan JA, Bradley SF, He X, Zarins LT, Ridenour GL, Tiballi RN, Kauffman CA. 1994. Epidemiology of oral candidiasis in HIV-infected patients: colonization, infection, treatment, and emergence of fluconazole resistance. Am J Med 97:339–346. http://dx.doi.org/10.1016/0002-9343(94)90300-X.
5. Willis AM, Coulter WA, Fulton CR, Hayes JR, Bell PM, Lamey PJ. 1999. Oral candidal carriage and infection in insulin-treated diabetic patients. Diabet Med 16:675– 679. http://dx.doi.org/10.1046/j.1464-5491.1999.00134.x.
6. Sobel JD. 1985. Epidemiology and pathogenesis of recurrent vulvovaginal candidiasis. Am J Obstet Gynecol 152:924–935. http://dx.doi.org/10.1016/S0002-9378(85)80003-X.
7. Sobel JD, Faro S, Force RW, Foxman B, Ledger WJ, Nyirjesy PR, Reed BD, Summers PR. 1998. Vulvovaginal candidiasis: epidemiologic, diagnostic, and therapeutic considerations. Am J Obstet Gynecol 178: 203–211. http://dx.doi.org/10.1016/S0002-9378(98)80001-X.
8. Sobel JD. 2007. Vulvovaginal candidosis. Lancet 369:1961–1971. http://dx.doi.org/10.1016/S0140-6736(07)60917-9.
9. Workowski KA, Berman S, Centers for Disease Control and Prevention. 2010. Sexually transmitted diseases treatment guidelines,2010. MMWR Recomm Rep 59:1–110.
10. Sobel JD. 1997. Vaginitis. N Engl J Med 337:1896 –1903. http://dx.doi.org/10.1056/NEJM199712253372607.
11. Fidel PL, Jr. 2002. The protective immune response against vaginal candidiasis: lessons learned from clinical studies and animal models. Int Rev Immunol 21:515–548. http://dx.doi.org/10.1080/08830180215015.
12. Fidel PL, Jr, Lynch ME, Redondo-Lopez V, Sobel JD, Robinson R. 1993. Systemic cell-mediated immune reactivity in women with recurrent vulvovaginal candidiasis. J Infect Dis 168:1458 –1465. http://dx.doi.org/10.1093/infdis/168.6.1458.
13. Fidel PL, Jr, Lynch ME, Sobel JD. 1995. Circulating CD4 and CD8 T cells have little impact on host defense against experimental vaginal candidiasis. Infect Immun 63:2403–2408.
14. Mendling W, Koldovsky U. 1996. Investigations by cell-mediated immunologic tests and therapeutic trials with thymopentin in vaginal mycoses. Infect Dis Obstet Gynecol 4:225–231. http://dx.doi.org/10.1155/S1064744996000439.
15. Wormley FL, Jr, Cutright J, Fidel PL, Jr. 2003. Multiple experimental designs to evaluate the role of T-cell-mediated immunity against experimental vaginal Candida albicans infection. Med Mycol 41:401– 409. http://dx.doi.org/10.1080/3693780310001597683.
16. Wozniak KL, Wormley FL, Jr, Fidel PL, Jr. 2002. Candida-specific antibodies during experimental vaginal candidiasis in mice. Infect Immun 70:5790 –5799. http://dx.doi.org/10.1128/IAI.70.10.5790-5799.2002.
17. Yano J, Kolls JK, Happel KI, Wormley F, Wozniak KL, Fidel PL, Jr. 2012. The acute neutrophil response mediated by S100 alarmins during vaginal Candida infections is independent of the Th17-pathway. PLoS One 7:e46311. http://dx.doi.org/10.1371/journal.pone.0046311.
18. Fidel PL, Jr, Barousse M, Espinosa T, Ficarra M, Sturtevant J, Martin DH, Quayle AJ, Dunlap K. 2004. An intravaginal live Candida challenge in humans leads to new hypotheses for the immunopathogenesis of vulvovaginal candidiasis. Infect Immun 72:2939–2946. http://dx.doi.org/10.1128/IAI.72.5.2939-2946.2004.
19. Peters BM, Palmer GE, Nash AK, Lilly EA, Fidel PL, Jr, Noverr MC. 2014. Fungal morphogenetic pathways are required for the hallmark inflammatory response during Candida albicans vaginitis. Infect Immun 82:532–543. http://dx.doi.org/10.1128/IAI.01417-13.
20. Yano J, Lilly E, Barousse M, Fidel PL, Jr. 2010. Epithelial cell-derived S100 calcium-binding proteins as key mediators in the hallmark acute neutrophil response during Candida vaginitis. Infect Immun 78: 5126–5137. http://dx.doi.org/10.1128/IAI.00388-10.
21. Yano J, Palmer GE, Eberle KE, Peters BM, Vogl T, McKenzie AN, Fidel PL, Jr. 2014. Vaginal epithelial cell-derived S100 alarmins induced by Candida albicans via pattern recognition receptor interactions are sufficient but not necessary for the acute neutrophil response during experimental vaginal candidiasis. Infect Immun 82:783–792. http://dx.doi.org/10.1128/IAI.00861-13.
22. Clark RA, Blakley SA, Rice J, Brandon W. 1995. Predictors of HIV disease progression in women. J Acquir Immune Defic Syndr Hum Retrovirol 9:43–50. http://dx.doi.org/10.1097/00042560-199505010-00007.
23. Fidel PL, Jr. 2002. Distinct protective host defenses against oral and vaginal candidiasis. Med Mycol 40:359–375. http://dx.doi.org/10.1080/mmy.40.4.359.375.
24. Imam N, Carpenter CC, Mayer KH, Fisher A, Stein M, Danforth SB. 1990. Hierarchical pattern of mucosal candida infections in HIVseropositive women. Am J Med 89:142–146. http://dx.doi.org/10.1016/0002-9343(90)90291-K.
25. Rhoads JL, Wright DC, Redfield RR, Burke DS. 1987. Chronic vaginal candidiasis in women with human immunodeficiency virus infection. JAMA 257:3105–3107. http://dx.doi.org/10.1001/jama.1987.03390220103029.
26. Schuman P, Sobel JD, Ohmit SE, Mayer KH, Carpenter CC, Rompalo A, Duerr A, Smith DK, Warren D, Klein RS. 1998. Mucosal candidal colonization and candidiasis in women with or at risk for human immunodeficiency virus infection. HIV Epidemiology Research Study (HERS) Group. Clin Infect Dis 27:1161–1167. http://dx.doi.org/10.1086/514979.
27. White MH. 1996. Is vulvovaginal candidiasis an AIDS-related illness? Clin Infect Dis 22(Suppl 2):S124 –S127. http://dx.doi.org/10.1093/clinids/22.Supplement_2.S124.
28. Conti HR, Shen F, Nayyar N, Stocum E, Sun JN, Lindemann MJ, Ho AW, Hai JH, Yu JJ, Jung JW, Filler SG, Masso-Welch P, Edgerton M, Gaffen SL. 2009. Th17 cells and IL-17 receptor signaling are essential for mucosal host defense against oral candidiasis. J Exp Med 206:299–311. http://dx.doi.org/10.1084/jem.20081463.
29. Moyes DL, Murciano C, Runglall M, Islam A, Thavaraj S, Naglik JR. 2011. Candida albicans yeast and hyphae are discriminated by MAPK signaling in vaginal epithelial cells. PLoS One 6:e26580. http://dx.doi.org/10.1371/journal.pone.0026580.
30. Schaller M, Korting HC, Borelli C, Hamm G, Hube B. 2005. Candida albicans-secreted aspartic proteinases modify the epithelial cytokine response in an in vitro model of vaginal candidiasis. Infect Immun 73: 2758–2765. http://dx.doi.org/10.1128/IAI.73.5.2758-2765.2005.
31. Wagner RD, Johnson SJ. 2012. Probiotic lactobacillus and estrogen effects on vaginal epithelial gene expression responses to Candida albicans. J Biomed Sci 19:58. http://dx.doi.org/10.1186/1423-0127-19-58.
32. De Luca A, Carvalho A, Cunha C, Iannitti RG, Pitzurra L, Giovannini G, Mencacci A, Bartolommei L, Moretti S, Massi-Benedetti C, Fuchs D, De Bernardis F, Puccetti P, Romani L. 2013. IL-22 and IDO1 affect immunity and tolerance to murine and human vaginal candidiasis. PLoS Pathog 9:e1003486. http://dx.doi.org/10.1371/journal.ppat.1003486.
33. Fidel PL, Jr, Wolf NA, KuKuruga MA. 1996. T lymphocytes in the murine vaginal mucosa are phenotypically distinct from those in the periphery. Infect Immun 64:3793–3799.
34. Pietrella D, Rachini A, Pines M, Pandey N, Mosci P, Bistoni F, d’Enfert C, Vecchiarelli A. 2011. Th17 cells and IL-17 in protective immunity to vaginal candidiasis. PLoS One 6:e22770. http://dx.doi.org/10.1371/journal.pone.0022770.
35. Basso B, Giménez F, López C. 2005. IL-1beta, IL-6 and IL-8 levels in gyneco-obstetric infections. Infect Dis Obstet Gynecol 13:207–211. http://dx.doi.org/10.1080/10647440500240664.
36. Fidel PL, Jr, Barousse M, Lounev V, Espinosa T, Chesson RR, Dunlap K. 2003. Local immune responsiveness following intravaginal challenge with Candida antigen in adult women at different stages of the menstrual cycle. Med Mycol 41:97–109. http://dx.doi.org/10.1080/mmy.41.2.97.109.
37. Latz E, Xiao TS, Stutz A. 2013. Activation and regulation of the inflammasomes. Nat Rev Immunol 13:397– 411. http://dx.doi.org/10.1038/nri3452.
38. Schroder K, Tschopp J. 2010. The inflammasomes. Cell 140:821–832. http://dx.doi.org/10.1016/j.cell.2010.01.040.
39. Yano J, Fidel PL, Jr. 8 December 2011. Protocols for vaginal inoculation and sample collection in the experimental mouse model of Candida vaginitis. J Vis Exp http://dx.doi.org/10.3791/3382..
40. Brummer E, Sugar AM, Stevens DA. 1985. Enhanced oxidative burst in immunologically activated but not elicited polymorphonuclear leukocytes correlates with fungicidal activity. Infect Immun 49:396–401.
41. Barousse MM, Van Der Pol BJ, Fortenberry D, Orr D, Fidel PL, Jr. 2004. Vaginal yeast colonisation, prevalence of vaginitis, and associated local immunity in adolescents. Sex Transm Infect 80:48 –53. http://dx.doi.org/10.1136/sti.2002.003855.
42. De Bernardis F, Lucciarini R, Boccanera M, Amantini C, Arancia S, Morrone S, Mosca M, Cassone A, Santoni G. 2006. Phenotypic and functional characterization of vaginal dendritic cells in a rat model of Candida albicans vaginitis. Infect Immun 74:4282– 4294. http://dx.doi.org/10.1128/IAI.01714-05.
43. De Bernardis F, Santoni G, Boccanera M, Lucciarini R, Arancia S, Sandini S, Amantini C, Cassone A. 2010. Protection against rat vaginal candidiasis by adoptive transfer of vaginal B lymphocytes. FEMS Yeast Res 10:432–440. http://dx.doi.org/10.1111/j.1567-1364.2010.00620.x.
44. Ferwerda B, Ferwerda G, Plantinga TS, Willment JA, van Spriel AB, Venselaar H, Elbers CC, Johnson MD, Cambi A, Huysamen C, Jacobs L, Jansen T, Verheijen K, Masthoff L, Morré SA, Vriend G, Williams DL, Perfect JR, Joosten LA, Wijmenga C, van der Meer JW, Adema GJ, Kullberg BJ, Brown GD, Netea MG. 2009. Human dectin-1 deficiency and mucocutaneous fungal infections. N Engl J Med 361:1760–1767. http://dx.doi.org/10.1056/NEJMoa0901053.
45. Whiley RA, Cruchley AT, Gore C, Hagi-Pavli E. 2012. Candida albicans strain-dependent modulation of pro-inflammatory cytokine release by in vitro oral and vaginal mucosal models. Cytokine 57:89–97. http://dx.doi.org/10.1016/j.cyto.2011.10.017.
46. De Bernardis F, Santoni G, Boccanera M, Spreghini E, Adriani D, Morelli L, Cassone A. 2000. Local anticandidal immune responses in a rat model of vaginal infection by and protection against Candida albicans. Infect Immun 68:3297–3304. http://dx.doi.org/10.1128/IAI.68.6.3297-3304.2000.
47. Fidel PL, Jr, Ginsburg KA, Cutright JL, Wolf NA, Leaman D, Dunlap K, Sobel JD. 1997. Vaginal-associated immunity in women with recurrent vulvovaginal candidiasis: evidence for vaginal Th1-type responses following intravaginal challenge with Candida antigen. J Infect Dis 176: 728–739. http://dx.doi.org/10.1086/514097.
48. Saavedra M, Taylor B, Lukacs N, Fidel PL, Jr. 1999. Local production of chemokines during experimental vaginal candidiasis. Infect Immun 67:5820–5826.
49. Steele C, Fidel PL, Jr. 2002. Cytokine and chemokine production by human oral and vaginal epithelial cells in response to Candida albicans. Infect Immun 70:577–583. http://dx.doi.org/10.1128/IAI.70.2.577-583.2002.
50. Fan SR, Liao QP, Liu XP, Liu ZH, Zhang D. 2008. Vaginal allergic response in women with vulvovaginal candidiasis. Int J Gynaecol Obstet 101:27–30. http://dx.doi.org/10.1016/j.ijgo.2007.08.024.
51. Schaller M, Mailhammer R, Grassl G, Sander CA, Hube B, Korting HC. 2002. Infection of human oral epithelia with Candida species induces cytokine expression correlated to the degree of virulence. J Invest Dermatol 118:652– 657. http://dx.doi.org/10.1046/j.1523-1747.2002.01699.x.
52. Taylor BN, Saavedra M, Fidel PL, Jr. 2000. Local Th1/Th2 cytokine production during experimental vaginal candidiasis: potential importance of transforming growth factor-beta. Med Mycol 38:419 – 431. http://dx.doi.org/10.1080/mmy.38.6.419.431.
53. Tomalka J, Ganesan S, Azodi E, Patel K, Majmudar P, Hall BA, Fitzgerald KA, Hise AG. 2011. A novel role for the NLRC4 inflammasome in mucosal defenses against the fungal pathogen Candida albicans. PLoS Pathog 7:e1002379. http://dx.doi.org/10.1371/journal.ppat.1002379.
54. Villamón E, Gozalbo D, Roig P, Murciano C, O’Connor JE, Fradelizi D, Gil ML. 2004. Myeloid differentiation factor 88 (MyD88) is required for murine resistance to Candida albicans and is critically involved in Candida-induced production of cytokines. Eur Cytokine Netw 15: 263–271.
55. Vonk AG, Netea MG, van Krieken JH, Iwakura Y, van der Meer JW, Kullberg BJ. 2006. Endogenous interleukin (IL)-1 alpha and IL-1beta are crucial for host defense against disseminated candidiasis. J Infect Dis 193:1419–1426. http://dx.doi.org/10.1086/503363.
56. Chen S, Li S, Wu Y, Liu Z, Li J. 2008. Local expression of vaginal Th1 and Th2 cytokines in murine vaginal candidiasis under different immunity conditions. J Huazhong Univ Sci Technolog Med Sci 28:476–479. http://dx.doi.org/10.1007/s11596-008-0423-z.
57. Lev-Sagie A, Nyirjesy P, Tarangelo N, Bongiovanni AM, Bayer C, Linhares IM, Giraldo PC, Ledger WJ, Witkin SS. 2009. Hyaluronan in vaginal secretions: association with recurrent vulvovaginal candidiasis. Am J Obstet Gynecol 201:206.e1–206.e5. http://dx.doi.org/10.1016/j.ajog.2009.05.010.
58. Derangère V, Chevriaux A, Courtaut F, Bruchard M, Berger H, Chalmin F, Causse SZ, Limagne E, Végran F, Ladoire S, Simon B, Boireau W, Hichami A, Apetoh L, Mignot G, Ghiringhelli F, Rébé C. 2014. Liver X receptor beta activation induces pyroptosis of human and murine colon cancer cells. Cell Death Differ 21:1914 –1924. http://dx.doi.org/10.1038/cdd.2014.117.
59. Joly S, Sutterwala FS. 2010. Fungal pathogen recognition by the NLRP3 inflammasome. Virulence 1:276 –280. http://dx.doi.org/10.4161/viru.1.4.11482.
60. Sheedy FJ, Palsson-McDermott E, Hennessy EJ, Martin C, O’Leary JJ, Ruan Q, Johnson DS, Chen Y, O’Neill LA. 2010. Negative regulation of TLR4 via targeting of the proinflammatory tumor suppressor PDCD4 by the microRNA miR-21. Nat Immunol 11:141–147. http://dx.doi.org/10.1038/ni.1828.
61. Matzinger P. 2002. The danger model: a renewed sense of self. Science 296:301–305. http://dx.doi.org/10.1126/science.1071059.
62. Mills KH, Dungan LS, Jones SA, Harris J. 2013. The role of inflammasome-derived IL-1 in driving IL-17 responses. J Leukoc Biol 93:489–497. http://dx.doi.org/10.1189/jlb.1012543.
63. Van de Veerdonk FL, Netea MG, Dinarello CA, Joosten LA. 2011. Inflammasome activation and IL-1beta and IL-18 processing during infection. Trends Immunol 32:110 –116. http://dx.doi.org/10.1016/j.it.2011.01.003.
64. Hise AG, Tomalka J, Ganesan S, Patel K, Hall BA, Brown GD, Fitzgerald KA. 2009. An essential role for the NLRP3 inflammasome in host defense against the human fungal pathogen Candida albicans. Cell Host Microbe 5:487– 4 9 7. h t t p:// d x. d o i. o r g/1 0. 1 0 1 6/j.chom.2009.05.002.
65. Gross O, Poeck H, Bscheider M, Dostert C, Hannesschläger N, Endres S, Hartmann G, Tardivel A, Schweighoffer E, Tybulewicz V, Mocsai A, Tschopp J, Ruland J. 2009. Syk kinase signalling couples to the Nlrp3 inflammasome for anti-fungal host defence. Nature 459:433–436. http://dx.doi.org/10.1038/nature07965.
66. Joly S, Ma N, Sadler JJ, Soll DR, Cassel SL, Sutterwala FS. 2009. Cutting edge: Candida albicans hyphae formation triggers activation of the Nlrp3 inflammasome. J Immunol 183:3578–3581. http://dx.doi.org/10.4049/jimmunol.0901323.
67. Kummer JA, Broekhuizen R, Everett H, Agostini L, Kuijk L, Martinon F, van Bruggen R, Tschopp J. 2007. Inflammasome components NALP 1 and 3 show distinct but separate expression profiles in human tissues suggesting a site-specific role in the inflammatory response. J Histochem Cytochem 55:443–452. http://dx.doi.org/10.1369/jhc.6A7101.2006.
68. Lev-Sagie A, Prus D, Linhares IM, Lavy Y, Ledger WJ, Witkin SS. 2009. Polymorphism in a gene coding for the inflammasome component NALP3 and recurrent vulvovaginal candidiasis in women with vulvar vestibulitis syndrome. Am J Obstet Gynecol 200:303.e1–303.e6. http://dx.doi.org/10.1016/j.ajog.2008.10.039.
69. Monod M, Togni G, Hube B, Sanglard D. 1994. Multiplicity of genes encoding secreted aspartic proteinases in Candida species. Mol Microbiol 13:357–368. http://dx.doi.org/10.1111/j.1365-2958.1994.tb00429.x.
70. Sanglard D, Hube B, Monod M, Odds FC, Gow NA. 1997. A triple deletion of the secreted aspartyl proteinase genes SAP4, SAP5, and SAP6 of Candida albicans causes attenuated virulence. Infect Immun 65: 3539–3546.
71. Ashman RB. 2008. Protective and pathologic immune responses against Candida albicans infection. Front Biosci 13:3334 –3351. http://dx.doi.org/10.2741/2929.
72. Peters BM, Yano J, Noverr MC, Fidel PL, Jr. 2014. Candida vaginitis: when opportunism knocks, the host responds. PLoS Pathog 10: e1003965. http://dx.doi.org/10.1371/journal.ppat.1003965.
73. McClure R, Massari P. 2014. TLR-dependent human mucosal epithelial cell responses to microbial pathogens. Front Immunol 5:386. http://dx.doi.org/10.3389/fimmu.2014.00386.
74. Biondo C, Signorino G, Costa A, Midiri A, Gerace E, Galbo R, Bellantoni A, Malara A, Beninati C, Teti G, Mancuso G. 2011. Recognition of yeast nucleic acids triggers a host-protective type I interferon response. Eur J Immunol 41:1969 –1979. http://dx.doi.org/10.1002/ eji.201141490.
75. Kasperkovitz PV, Khan NS, Tam JM, Mansour MK, Davids PJ, Vyas JM. 2011. Toll-like receptor 9 modulates macrophage antifungal effector function during innate recognition of Candida albicans and Saccharomyces cerevisiae. Infect Immun 79:4858–4867. http://dx.doi.org/10.1128/ IAI.05626-11.
76. Nahum A, Dadi H, Bates A, Roifman CM. 2012. The biological significance of TLR3 variant, L412F, in conferring susceptibility to cutaneous candidiasis, CMV and autoimmunity. Autoimmun Rev 11:341–347. http://dx.doi.org/10.1016/j.autrev.2011.10.007.
77. Gross O, Gewies A, Finger K, Schäfer M, Sparwasser T, Peschel C, Förster I, Ruland J. 2006. Card9 controls a non-TLR signalling pathway for innate anti-fungal immunity. Nature 442:651– 656. http://dx.doi.org/10.1038/nature04926.
78. Vonk AG, Netea MG, Kullberg BJ. 2012. Phagocytosis and intracellular killing of Candida albicans by murine polymorphonuclear neutrophils. Methods Mol Biol 845:277–287. http://dx.doi.org/10.1007/978-1-61779-539-8_18.
79. Lasarte S, Elsner D, Guía-González M, Ramos-Medina R, Sánchez- Ramón S, Esponda P, Muñoz-Fernández MA, Relloso M. 2013. Female sex hormones regulate the Th17 immune response to sperm and Candida albicans. Hum Reprod 28:3283–3291. http://dx.doi.org/10.1093/humrep/det348.
80. Relloso M, Aragoneses-Fenoll L, Lasarte S, Bourgeois C, Romera G, Kuchler K, Corbí AL, Muñoz-Fernández MA, Nombela C, Rodríguez- Fernández JL, Diez-Orejas R. 2012. Estradiol impairs the Th17 immune response against Candida albicans. J Leukoc Biol 91:159 –165. http:// dx.doi.org/10.1189/jlb.1110645.
81. Bauernfeind FG, Horvath G, Stutz A, Alnemri ES, MacDonald K, Speert D, Fernandes-Alnemri T, Wu J, Monks BG, Fitzgerald KA, Hornung V, Latz E. 2009. Cutting edge: NF-kappaB activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression. J Immunol 183:787–791. http://dx.doi.org/10.4049/jimmunol.0901363.
82. Franchi L, Eigenbrod T, Núñez G. 2009. Cutting edge: TNF-alpha mediates sensitization to ATP and silica via the NLRP3 inflammasome in the absence of microbial stimulation. J Immunol 183:792–796. http://dx.doi.org/10.4049/jimmunol.0900173.
83. Netea MG, Ferwerda G, van der Graaf CA, Van der Meer JW, Kullberg BJ. 2006. Recognition of fungal pathogens by Toll-like receptors. Curr Pharm Des 1 2:4195– 4201. h t t p:// d x. d o i. o r g/1 0. 2 1 7 4/138161206778743538.
84. Eklund KK, Niemi K, Kovanen PT. 2012. Immune functions of serum amyloid A. Crit Rev Immunol 32:335–348. http://dx.doi.org/10.1615/CritRevImmunol.v32.i4.40.
85. Migita K, Izumi Y, Jiuchi Y, Kozuru H, Kawahara C, Nakamura M, Nakamura T, Agematsu K, Masumoto J, Yasunami M, Kawakami A, Eguchi K. 2014. Serum amyloid A induces NLRP-3-mediated IL-1beta secretion in neutrophils. PLoS One 9:e96703. http://dx.doi.org/10.1371/journal.pone.0096703.
86. Yu N, Liu S, Yi X, Zhang S, Ding Y. 2015. Serum amyloid A induces IL-1beta secretion from keratinocytes via the NLRP3 Inflammasome. Clin Exp Immunol 179:344 –353. http://dx.doi.org/10.1111/cei.12458.
87. Rajamäki K, Lappalainen J, Oörni K, Välimäki E, Matikainen S, Kovanen PT, Eklund KK. 2010. Cholesterol crystals activate the NLRP3 inflammasome in human macrophages: a novel link between cholesterol metabolism and inflammation. PLoS One 5:e11765. http://dx.doi.org/ 10.1371/journal.pone.0011765.
88. Taylor BN, Staib P, Binder A, Biesemeier A, Sehnal M, Röllinghoff M, Morschhäuser J, Schröppel K. 2005. Profile of Candida albicanssecreted aspartic proteinase elicited during vaginal infection. Infect Im- mun 73:1828 –1835. http://dx.doi.org/10.1128/IAI.73.3.1828-1835.2005.
89. Staib P, Kretschmar M, Nichterlein T, Hof H, Morschhäuser J. 2002. Transcriptional regulators Cph1p and Efg1p mediate activation of the Candida albicans virulence gene SAP5 during infection. Infect Immun 70:921–927. http://dx.doi.org/10.1128/IAI.70.2.921-927.2002.
90. Borg-von Zepelin M, Beggah S, Boggian K, Sanglard D, Monod M. 1998. The expression of the secreted aspartyl proteinases Sap4 to Sap6 from Candida albicans in murine macrophages. Mol Microbiol 28: 543–554. http://dx.doi.org/10.1046/j.1365-2958.1998.00815.x.
91. Naglik JR, Moyes D, Makwana J, Kanzaria P, Tsichlaki E, Weindl G, Tappuni AR, Rodgers CA, Woodman AJ, Challacombe SJ, Schaller M, Hube B. 2008. Quantitative expression of the Candida albicans secreted aspartyl proteinase gene family in human oral and vaginal candidiasis. Microbiology 154:3266 –3280. http://dx.doi.org/10.1099/mic.0.2008/022293-0.
92. Naglik JR, Rodgers CA, Shirlaw PJ, Dobbie JL, Fernandes-Naglik LL, Greenspan D, Agabian N, Challacombe SJ. 2003. Differential expression of Candida albicans secreted aspartyl proteinase and phospholipase B genes in humans correlates with active oral and vaginal infections. J Infect Dis 188:469–479. http://dx.doi.org/10.1086/376536.
93. Pietrella D, Pandey N, Gabrielli E, Pericolini E, Perito S, Kasper L, Bistoni F, Cassone A, Hube B, Vecchiarelli A. 2013. Secreted aspartic proteases of Candida albicans activate the NLRP3 inflammasome. Eur J Immunol 43:679–692. http://dx.doi.org/10.1002/eji.201242691.
94. Office of Laboratory Animal Welfare. 2015. Public Health Service policy on humane care and use of laboratory animals. Office of Laboratory Animal Welfare, Public Health Service, Bethesda, MD. http://grants.nih.gov/grants/olaw/references/phspol.htm.
95. National Research Council. 2011. Guide for the care and use of laboratory animals, 8th ed. National Academies Press, Washington, DC.
96. Code of Federal Regulations. 2013. Title 7. Agriculture. Chapter 54. Transportation, Sale, and Handling of Certain Animals. Sections 2131–2159. Animal Welfare Act. 7 U.S.C. 2131–2159.
97. American Veterinary Medical Association. 2013. AVMA guidelines for the euthanasia of animals, 2013 ed. American Veterinary Medical Association, Schaumburg, IL.
98. Correia A, Lermann U, Teixeira L, Cerca F, Botelho S, da Costa RM, Sampaio P, Gärtner F, Morschhäuser J, Vilanova M, Pais C. 2010. Limited role of secreted aspartyl proteinases Sap1 to Sap6 in Candida albicans virulence and host immune response in murine hematogenously disseminated candidiasis. Infect Immun 78:4839 – 4849. http://dx.doi.org/10.1128/IAI.00248-10.
99. Gillum AM, Tsay EY, Kirsch DR. 1984. Isolation of the Candida albicans gene for orotidine-5=-phosphate decarboxylase by complementation of S. cerevisiae ura3 and E. coli pyrF mutations. Mol Gen Genet 198: 179–182. http://dx.doi.org/10.1007/BF00328721.
100. Jackson BE, Wilhelmus KR, Hube B. 2007. The role of secreted aspartyl proteinases in Candida albicans keratitis. Invest Ophthalmol Vis Sci 48: 3559–3565. http://dx.doi.org/10.1167/iovs.07-0114.
101. Donegan K, Matyac C, Seidler R, Porteous A. 1991. Evaluation of methods for sampling, recovery, and enumeration of bacteria applied to the phylloplane. Appl Environ Microbiol 57:51–56.
102. Kim D, Pertea G, Trapnell C, Pimentel H, Kelley R, Salzberg SL. 2013. TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions. Genome Biol 14:R36. http:// dx.doi.org/10.1186/gb-2013-14-4-r36.
103. Anders S, Huber W. 2010. Differential expression analysis for sequence count data. Genome Biol 11:R106. http://dx.doi.org/10.1186/gb-2010 -11-10-r106.
104. Livak KJ, Schmittgen TD. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2CT method. Methods 25: 402–408. http://dx.doi.org/10.1006/meth.2001.1262.